Meosuc-aapm-pna is a chromogenic peptide substrate containing an activated nitroanilide group for monitoring proteolytic cleavage. The sequence architecture provides well-defined recognition elements for mapping enzyme specificity. Researchers employ it for kinetic profiling and structure-function studies. Its ester-linked protecting groups enhance solubility and stability in assay systems.
CAT No: R2252
CAS No:70967-91-8
Synonyms/Alias:MEOSUC-AAPM-PNA;70967-91-8;methyl 4-[[1-[[1-[2-[[4-methylsulfanyl-1-(4-nitroanilino)-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoate;N-Methoxysuccinyl-Ala-Ala-Pro-Met p-nitroanilide;CATHEPSIN G SUBSTRATE;DTXSID20404147;VCA96791;AS-87836;G77868;N-Methoxysuccinyl-Ala-Ala-Pro-Met p-nitroanilide, >95% (HPLC);
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.